Clinical trials: Lymphadenopathy Retroperitoneal, open to volunteers
Lymphadenopathy Retroperitoneal, Stage II Testicular Seminoma
R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
This study will investigate the safety and efficacy of using robotic retroperitoneal lymph node dissection (R-RPLND), a minimally invasive surgical approach, as the first-line of treatment for stage IIA/B (or equivalent) seminoma…
- Trial name
- NCT05345158
- Testing
- Robotic Retroperitoneal Lymph Node Dissection (RPLND)
- Where
- Canada
- Volunteers
- 25 people
- Sponsor
- University Health Network, Toronto